These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37942377)

  • 21. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.
    Hatmal MM; Al-Hatamleh MAI; Olaimat AN; Hatmal M; Alhaj-Qasem DM; Olaimat TM; Mohamud R
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34073382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of COVID-19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: A cross-sectional study.
    Yasmin F; Najeeb H; Siddiqui HF; Asghar MS; Awan HA; Usama RM; Allahuddin Z; Tahir MJ; Ullah K; Mahmmoud Fadelallah Eljack M
    Health Sci Rep; 2023 Jan; 6(1):e1071. PubMed ID: 36698706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimorbidity and Its Effect on Self-Reported Adverse Effects Following COVID-19 Vaccination.
    Riyyan M; Sajid S; Hotwani S; Chania HA; Shaikh MS; Sadiq Y; Sarwar HA; Azeem A; Memon SM; Abid S
    Cureus; 2022 Dec; 14(12):e33139. PubMed ID: 36721563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19: vaccination vs. hospitalization.
    Uzun O; Akpolat T; Varol A; Turan S; Bektas SG; Cetinkaya PD; Dursun M; Bakan N; Ketencioglu BB; Bayrak M; Baris SA; Guner R; Gunal O; Nural S; Deniz PP; Toprak OB; Ozkan G; Gumus A; Kerget F; Ercelik M; Ataoglu O; Yuksel A; Ates G; Kutsoylu OE; Kose N; Kizilirmak D; Keskin S; Gultekin O; Coskun N; Yilmaz ES; Uslu S; Basyigit İ; Ergan B; Deveci F; Yakar MN; Zuhur C; Sagcan G; Yuce ZT; Kuluozturk M; Sezgin ME; Sezgin ENA; Havlucu Y; Cuhadaroglu C; Kilinc O; Boyaci H; Altunay H; Akti M; Dursun ZB; Kalem AK; Isik SA; Akyildiz L; Aykac N; Almaz MS; Kokturk N; Itil O
    Infection; 2022 Jun; 50(3):747-752. PubMed ID: 34984646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events following immunisation of COVID-19 vaccine among health care workers in the first phase of vaccination.
    Rahmat H; Leelavathi M; Wan Ismail WF
    Med J Malaysia; 2022 Nov; 77(6):637-642. PubMed ID: 36448378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side Effects Associated With Homologous and Heterologous COVID-19 Vaccines: A Cross-Sectional Study in Saudi Arabia.
    Mohammed RA; Yazbik RS; Baajajah LH; Alharthy SF; Alsalahi H; Mahjaa MA; Barakat MM; Badawy MI; Sultan I
    Cureus; 2023 Jan; 15(1):e34030. PubMed ID: 36814743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance of Side Effects after Two Doses of COVID-19 Vaccines among Patients with Comorbid Conditions: A Sub-Cohort Analysis from Saudi Arabia.
    Mallhi TH; Khan YH; Butt MH; Salman M; Tanveer N; Alotaibi NH; Alzarea AI; Alanazi AS
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study.
    Mohsin M; Mahmud S; Uddin Mian A; Hasan P; Muyeed A; Taif Ali M; Faysal Ahmed F; Islam A; Maliha Rahman M; Islam M; Rahaman Khan MH; Shafiqur Rahman M
    Vaccine X; 2022 Dec; 12():100207. PubMed ID: 36032698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Retrospective Evaluation of Self-Reported Adverse Events Following Immunization with Different COVID-19 Vaccines in Türkiye.
    Büyüker SM; Sultana A; Chowdhury JA; Chowdhury AA; Kabir S; Amran MS
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, effectiveness and hesitancy of COVID-19 vaccination in children: A cross-sectional study in Pakistan.
    Zaufishan Z; Usman M; Fishan Mumtaz K; Bilal R; Arshad A; Khan HM
    Front Public Health; 2022; 10():1084017. PubMed ID: 36733278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan.
    Riyyan M; Sarwar HA; Chania HA; Sajid S; Hotwani S; Sarwar HU; Nawaz S; Abid S
    Cureus; 2022 Nov; 14(11):e31359. PubMed ID: 36514568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia.
    Tan AY; Chang CT; Yu YK; Low YX; Razali NFM; Tey SY; Lee SWH
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review.
    Dadras O; Mehraeen E; Karimi A; Tantuoyir MM; Afzalian A; Nazarian N; Mojdeganlou H; Mirzapour P; Shamsabadi A; Dashti M; Ghasemzadeh A; Vahedi F; Shobeiri P; Pashaei Z; SeyedAlinaghi S
    Arch Acad Emerg Med; 2022; 10(1):e54. PubMed ID: 36033990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term Side Effects of mRNA-based COVID-19 Vaccine Among Jordanian Population; a Cross-sectional Study.
    Nassar RI
    Arch Acad Emerg Med; 2023; 11(1):e22. PubMed ID: 36919138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Side Effects of COVID-19 Vaccines and Its Association With ABO Blood Type Among the General Surgeons in Saudi Arabia.
    Alessa MY; Aledili FJ; Alnasser AA; Aldharman SS; Al Dehailan AM; Abuseer HO; Almohammed Saleh AA; Alsalem HA; Alsadiq HM; Alsultan AS
    Cureus; 2022 Mar; 14(3):e23628. PubMed ID: 35494934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intricacies Affiliated With Post-COVID Vaccine Complications in Makkah Province, Saudi Arabia.
    Sheriff MM; Basalib SG; Mereani MJ; Bakhsh LM; Alzamzami BA; Garout RM
    Cureus; 2022 Dec; 14(12):e32749. PubMed ID: 36578849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Side effects after COVID-19 vaccination: a comparison between the most common available vaccines in Iran.
    Yadegarynia D; Tehrani S; Hadavand F; Arshi S; Abtahian Z; Keyvanfar A; Darvishi A; Zarghi A; Gachkar L; Darazam IA; Farahbakhsh M
    Iran J Microbiol; 2023 Apr; 15(2):189-195. PubMed ID: 37193234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan.
    Beg BM; Hussain T; Ahmad M; Areej S; Majeed A; Rasheed MA; Ahmad MM; Shoaib QU; Aroosa S
    PLoS One; 2022; 17(3):e0266028. PubMed ID: 35324978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe.
    Rosenblum HG; Gee J; Liu R; Marquez PL; Zhang B; Strid P; Abara WE; McNeil MM; Myers TR; Hause AM; Su JR; Markowitz LE; Shimabukuro TT; Shay DK
    Lancet Infect Dis; 2022 Jun; 22(6):802-812. PubMed ID: 35271805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.